Clinical Trials

Only 50 percent of clinical trial results in Europe are reported, but big pharma shares far less than half the blame.

The PRGLAC Task Force hopes to change the landscape for research on pregnant and lactating women.

Including pregnant women in research isn’t as difficult as some might think…

One pharma company is working to pioneer safer drugs for use during pregnancy…

The lack of evidence available from pharma companies to guide care of pregnant women is ethically unacceptable.

Is pharma putting women and children last?

It’s time for maternal health to move on from the dark ages, and pharma has a duty to help.

Sitting Down With…Danny Bar-Zohar, Global Head of Neuroscience Development at Novartis, Switzerland

A promising candidate is on the verge of entering clinical development… What happens when you see an opportunity to make it even better?

“Right to Try” legislation may have compassion at its heart, but it does not do enough to ensure patient protection.